Paul Schimmel, Director at aTYR PHARMA INC (ATYR), bought 100,000 shares at $0.50 ($50K) on 2026-05-27, disclosed to the SEC on 2026-05-28.
Open-market purchase of $50k ATYR by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| LIFE | BUY | 2023-05-11 | $450K | — | Filing → |
| LIFE | BUY | 2021-09-22 | $2.0M | — | Filing → |
| LIFE | BUY | 2021-05-20 | $199K | — | Filing → |